130 related articles for article (PubMed ID: 26131142)
1. Matrine regulates immune functions to inhibit the proliferation of leukemic cells.
Zhang L; Zhang H; Zhu Z; Jiang L; Lu X; Zhou M; Sun X; He L; Bai Y; Ma L
Int J Clin Exp Med; 2015; 8(4):5591-600. PubMed ID: 26131142
[TBL] [Abstract][Full Text] [Related]
2. [Effects of matrine on the expression of NKG2D ligands in leukemia cells].
Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024
[TBL] [Abstract][Full Text] [Related]
3. Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.
Lu X; Zhu Z; Jiang L; Sun X; Jia Z; Qian S; Li J; Ma L
Am J Transl Res; 2015; 7(10):1838-49. PubMed ID: 26692928
[TBL] [Abstract][Full Text] [Related]
4. [Up-regulation of NKG2D ligand ULBP2 by matrine in K562 cells and the underlying molecular mechanisms].
Ma L; Zhu Z; Lu X; Jiang L; Zhou M; Qian S; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):438-42. PubMed ID: 24857216
[TBL] [Abstract][Full Text] [Related]
5. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
[TBL] [Abstract][Full Text] [Related]
6. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
[TBL] [Abstract][Full Text] [Related]
7. [Roles of NKG2D in cytokine-induced killer (CIK) against hematological malignant cells lines].
He JY; Jia ZX; Cai XH; Han WM; Xiao R; Ma LD; Lu XZ; Zhou M; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1380-4. PubMed ID: 24370015
[TBL] [Abstract][Full Text] [Related]
8. [NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1].
Lu XZ; Cai XH; Ma LD; Chen BA
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):444-7. PubMed ID: 22967377
[TBL] [Abstract][Full Text] [Related]
9. STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells.
Cai X; Lu X; Jia Z; Zhang X; Han W; Rong X; Ma L; Zhou M; Chen B
Int J Hematol; 2015 Nov; 102(5):536-43. PubMed ID: 26387089
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
11. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack.
Vinnars MT; Björk E; Nagaev I; Ottander U; Bremme K; Holmlund U; Sverremark-Ekström E; Mincheva-Nilsson L
Am J Reprod Immunol; 2018 Jul; 80(1):e12969. PubMed ID: 29741244
[TBL] [Abstract][Full Text] [Related]
14. [Expression of HLA class I molecules and MHC class I chain-related molecules A/B in K562 and K562/AO2 cell lines and their effects on cytotoxicity of NK cells].
Mei JZ; Niu XQ; Guo KY; Zhou J; Wei HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):288-91. PubMed ID: 17493333
[TBL] [Abstract][Full Text] [Related]
15. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Epithelial-to-mesenchymal Transition on Biological Activity of NK Cells in Esophageal Squamous Cell Carcinoma].
Gao FX; Wu J; Ren DL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):40-47. PubMed ID: 31037903
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands.
Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E
Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced cytotoxicity against leukemia cells of natural Killer cells from cord blood after expansion in vitro].
Zhou F; Han WM; Jia ZX; Yang JH; Xiao R; Ma LD; Lu XZ
Zhonghua Xue Ye Xue Za Zhi; 2013 Nov; 34(11):952-6. PubMed ID: 24294851
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
